Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 10/2007

01-10-2007 | Original Article

Are there adaptive changes in the human brain of patients with Parkinson’s disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT

Authors: Stelvio Sestini, Alberto Pupi, Franco Ammannati, Ramat Silvia, Sandro Sorbi, Antonio Castagnoli

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2007

Login to get access

Abstract

Purpose

The aim of this follow-up study was to assess persistent motor and regional cerebral blood flow (rCBF) changes in patients with Parkinson’s disease (PD) treated with high-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN).

Methods

Ten PD patients with STN-DBS underwent three rCBF SPECT studies at rest, once preoperatively in the off-drug condition (T0), and twice postoperatively in the off-drug/off-stimulation conditions at 5 ± 2 (T1) and 42 ± 7 months (T2). Patients were assessed using the UPDRS, H&Y and S&E scales. SPM was used to investigate baseline rCBF changes from the preoperative condition to the postoperative conditions and the relationship between rCBF and UPDRS scores used as covariate of interest.

Results

Parkinsonian patients showed a clinical improvement which was significant only on follow-up at 42 months. The main effect of treatment from T0 to T1 was to produce baseline rCBF increases in the pre-supplementary motor area (pre-SMA), premotor cortex and somatosensory association cortex. From T1 to T2 a further baseline rCBF increase was detected in the pre-SMA (p < 0.0001). A correlation was detected between the slight improvement in motor scores and the rCBF increase in the pre-SMA (p < 0.0001), which is known to play a crucial role in clinical progression.

Conclusion

Our study suggests the presence of adaptive functional changes in the human brain of PD patients treated with long-term STN-DBS. Such adaptive processes seem to occur in the pre-SMA and to play only a slightly beneficial role in terms of functional compensation of motor impairment.
Literature
1.
go back to reference Hallett M. Plasticity. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 569–86. Hallett M. Plasticity. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 569–86.
3.
go back to reference Chollet F, Weiller C. Recovery of neurological function. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 587–97. Chollet F, Weiller C. Recovery of neurological function. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 587–97.
4.
go back to reference Valldeoriola F, Pilleri M, Tolosa E, Molinuevo JL, Rumia J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinson’s disease: long-term follow-up of patients. Mov Disord 2002;17:125–32.PubMedCrossRef Valldeoriola F, Pilleri M, Tolosa E, Molinuevo JL, Rumia J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinson’s disease: long-term follow-up of patients. Mov Disord 2002;17:125–32.PubMedCrossRef
5.
go back to reference Vingerhoets FJG, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson’s disease. Two-year follow-up. Neurology 2002;58:396–401.PubMed Vingerhoets FJG, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson’s disease. Two-year follow-up. Neurology 2002;58:396–401.PubMed
6.
go back to reference Haberler C, Alesch F, Mazal PR, Pilz P, Jellinger K, Pinter MM, et al. No tissue damage by chronic deep brain stimulation in Parkinson’s disease. Ann Neurol 2000;48:372–6.PubMedCrossRef Haberler C, Alesch F, Mazal PR, Pilz P, Jellinger K, Pinter MM, et al. No tissue damage by chronic deep brain stimulation in Parkinson’s disease. Ann Neurol 2000;48:372–6.PubMedCrossRef
7.
go back to reference Albin R, Young AB, Penny JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366–75.PubMedCrossRef Albin R, Young AB, Penny JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366–75.PubMedCrossRef
8.
go back to reference De Long MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281–5.CrossRef De Long MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281–5.CrossRef
9.
go back to reference Benazzouz A, Hallet M. Mechanism of action of deep brain stimulation. Neurology 2000;55 Suppl 6:13–6. Benazzouz A, Hallet M. Mechanism of action of deep brain stimulation. Neurology 2000;55 Suppl 6:13–6.
10.
11.
go back to reference Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidal stimulation in Parkinson’s disease. Ann Neurol 1997;42:283–91.PubMedCrossRef Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidal stimulation in Parkinson’s disease. Ann Neurol 1997;42:283–91.PubMedCrossRef
12.
go back to reference Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MTR, Passeri A, Martini S, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson’s disease. J Nucl Med 2002;43:725–32.PubMed Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MTR, Passeri A, Martini S, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson’s disease. J Nucl Med 2002;43:725–32.PubMed
13.
go back to reference Turner RS, Henry T, Grafton S. Therapeutics: surgical. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 613–32. Turner RS, Henry T, Grafton S. Therapeutics: surgical. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego, CA: Academic Press; 2000. p. 613–32.
14.
go back to reference Sestini S, Ramat S, Formiconi AR, Ammannati F, Sorbi S, Pupi A. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson’s disease: a 4-year follow-up study with rCBF SPECT. J Nucl Med 2005;46:1444–54.PubMed Sestini S, Ramat S, Formiconi AR, Ammannati F, Sorbi S, Pupi A. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson’s disease: a 4-year follow-up study with rCBF SPECT. J Nucl Med 2005;46:1444–54.PubMed
15.
go back to reference Boccacci P, Bonetto P, Calvini P, Formiconi AR. A simple model for the efficient correction of collimators blur in 3D SPECT images. Inv Probl 1999;15:907–30.CrossRef Boccacci P, Bonetto P, Calvini P, Formiconi AR. A simple model for the efficient correction of collimators blur in 3D SPECT images. Inv Probl 1999;15:907–30.CrossRef
16.
go back to reference Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–9.PubMed Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–9.PubMed
17.
go back to reference Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Human Brain Mapp 1995;3:165–89.CrossRef Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Human Brain Mapp 1995;3:165–89.CrossRef
18.
go back to reference Lancaster JL, Woldorff MG, Parsons LM. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapp 2000;10:120–31.CrossRef Lancaster JL, Woldorff MG, Parsons LM. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapp 2000;10:120–31.CrossRef
19.
go back to reference Benabid AL, Koudsie A, Benazzouz A, Piallat B, van Blerkom N, Fraix V, et al. Subthalamic nucleus deep brain stimulation. Prog Neurol Surg 2000;15:196–226.CrossRef Benabid AL, Koudsie A, Benazzouz A, Piallat B, van Blerkom N, Fraix V, et al. Subthalamic nucleus deep brain stimulation. Prog Neurol Surg 2000;15:196–226.CrossRef
20.
go back to reference Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 1998;51:850–5.PubMed Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 1998;51:850–5.PubMed
21.
go back to reference Molinuevo JL, Valldeoriola F, Tolosa E, Rumià J, Valls-Solé J, Roldan H, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000;57:983–8.PubMedCrossRef Molinuevo JL, Valldeoriola F, Tolosa E, Rumià J, Valls-Solé J, Roldan H, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000;57:983–8.PubMedCrossRef
22.
go back to reference Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, et al. Subthalamic nucleus stimulation in Parkinson’s disease. Clinical evaluation of 18 patients. J Neurol 2002;249:529–34.PubMedCrossRef Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, et al. Subthalamic nucleus stimulation in Parkinson’s disease. Clinical evaluation of 18 patients. J Neurol 2002;249:529–34.PubMedCrossRef
23.
go back to reference Rodriguez-Oroz MC, Gorospe LM, Guridi J, Ramos E, Linazasoro G, Rodriguez-Palmero M, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. Neurology 2000;55 Suppl 6:45–51. Rodriguez-Oroz MC, Gorospe LM, Guridi J, Ramos E, Linazasoro G, Rodriguez-Palmero M, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. Neurology 2000;55 Suppl 6:45–51.
24.
go back to reference Simuni T, Jaggi JL, Mulholland H, Hurtig H, Colcher A, Siderowe AD, et al. Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 2002;96:666–72.PubMed Simuni T, Jaggi JL, Mulholland H, Hurtig H, Colcher A, Siderowe AD, et al. Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 2002;96:666–72.PubMed
25.
go back to reference Østergaard K, Sunde N. Evolution of Parkinson’s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006;21:624–31.PubMedCrossRef Østergaard K, Sunde N. Evolution of Parkinson’s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006;21:624–31.PubMedCrossRef
26.
go back to reference Schüpbach WMM, Chastan N, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640–4.PubMedCrossRef Schüpbach WMM, Chastan N, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640–4.PubMedCrossRef
27.
go back to reference Geday J, Østergaard K, Gjedde A. Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus. Neuroimage 2006;33:706–14.PubMedCrossRef Geday J, Østergaard K, Gjedde A. Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus. Neuroimage 2006;33:706–14.PubMedCrossRef
28.
go back to reference Temperli P, Ghika J, Villemure JG, Burhard PR, Bogousslavsky J, Vingerhoets FJG. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003;60:78–81.PubMedCrossRef Temperli P, Ghika J, Villemure JG, Burhard PR, Bogousslavsky J, Vingerhoets FJG. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003;60:78–81.PubMedCrossRef
29.
go back to reference Maesawa S, Kaneoke Y, Kajita Y, Usui N, Misawa N, Nakayama A, et al. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 2004;100:679–87.PubMedCrossRef Maesawa S, Kaneoke Y, Kajita Y, Usui N, Misawa N, Nakayama A, et al. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 2004;100:679–87.PubMedCrossRef
30.
go back to reference Lokkegaard A, Werdelin LM, Regeur L, Karlsborg M, Jensen SR, Brodsgaard E, et al. Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease. Eur J Nucl Med Mol Imaging 2007;3:508–16.CrossRef Lokkegaard A, Werdelin LM, Regeur L, Karlsborg M, Jensen SR, Brodsgaard E, et al. Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease. Eur J Nucl Med Mol Imaging 2007;3:508–16.CrossRef
31.
go back to reference Seibyl J, Jennings D, Tabamo R, Marek K. Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson’s disease research. Q J Nucl Med Mol Imaging 2005;49:215–21.PubMed Seibyl J, Jennings D, Tabamo R, Marek K. Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson’s disease research. Q J Nucl Med Mol Imaging 2005;49:215–21.PubMed
32.
go back to reference Warnke PC. STN stimulation and neuroprotection in Parkinson’s disease—when beautiful theories meet ugly facts. J Neurol Neurosurg Psychiatry 2005;76:1186–7.PubMedCrossRef Warnke PC. STN stimulation and neuroprotection in Parkinson’s disease—when beautiful theories meet ugly facts. J Neurol Neurosurg Psychiatry 2005;76:1186–7.PubMedCrossRef
33.
go back to reference Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, et al. Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 2000;12:4141–6.PubMedCrossRef Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, et al. Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 2000;12:4141–6.PubMedCrossRef
34.
go back to reference Morrish P. Is it time to abandon functional imaging in the study of neuroprotection? Mov Disord 2002;17:229–32.PubMedCrossRef Morrish P. Is it time to abandon functional imaging in the study of neuroprotection? Mov Disord 2002;17:229–32.PubMedCrossRef
35.
go back to reference Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson’s disease is not dopamine-mediated. Trends Neurosci 2003;26:215–21.PubMedCrossRef Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson’s disease is not dopamine-mediated. Trends Neurosci 2003;26:215–21.PubMedCrossRef
36.
go back to reference Hess G, Aizenman CD, Donogue JP. Conditions for the induction of long-term potentiation on layer II/III horizontal connections of the rat motor cortex. J Neurophysiol 1996;75:1765–78.PubMed Hess G, Aizenman CD, Donogue JP. Conditions for the induction of long-term potentiation on layer II/III horizontal connections of the rat motor cortex. J Neurophysiol 1996;75:1765–78.PubMed
37.
go back to reference Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson’s disease: a functional MRI study. Brain 2000;123:394–403.PubMedCrossRef Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson’s disease: a functional MRI study. Brain 2000;123:394–403.PubMedCrossRef
38.
go back to reference Nudo RJ, Plautz EJ, Frost SB. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve 2001;24:1000–19.PubMedCrossRef Nudo RJ, Plautz EJ, Frost SB. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve 2001;24:1000–19.PubMedCrossRef
39.
go back to reference Hirsch EC. Nigrostriatal system plasticity in Parkinson’s disease: effect of dopaminergic denervation and treatment. Ann Neurol 2000;47 4 suppl 1:S115–20.PubMed Hirsch EC. Nigrostriatal system plasticity in Parkinson’s disease: effect of dopaminergic denervation and treatment. Ann Neurol 2000;47 4 suppl 1:S115–20.PubMed
40.
go back to reference Ziemann U, Hallett M, Cohen LG. Mechanisms of deafferentation-induced plasticity in human motor cortex. J Neurosci 1998;18:7000–7.PubMed Ziemann U, Hallett M, Cohen LG. Mechanisms of deafferentation-induced plasticity in human motor cortex. J Neurosci 1998;18:7000–7.PubMed
41.
go back to reference Keller A, Arissian K, Asanuma H. Synaptic proliferation in the motor cortex of adult cats after long-term thalamic stimulation. J Neurophysiol 2002;68:295–308.CrossRef Keller A, Arissian K, Asanuma H. Synaptic proliferation in the motor cortex of adult cats after long-term thalamic stimulation. J Neurophysiol 2002;68:295–308.CrossRef
42.
go back to reference Lang AE, Obeso JA. Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004;3:309–16.PubMedCrossRef Lang AE, Obeso JA. Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004;3:309–16.PubMedCrossRef
Metadata
Title
Are there adaptive changes in the human brain of patients with Parkinson’s disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT
Authors
Stelvio Sestini
Alberto Pupi
Franco Ammannati
Ramat Silvia
Sandro Sorbi
Antonio Castagnoli
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0428-z

Other articles of this Issue 10/2007

European Journal of Nuclear Medicine and Molecular Imaging 10/2007 Go to the issue